RecallDepth
Class I Ongoing

Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale).

This recall is currently active, issued December 3, 2025. It was issued by Fresenius Kabi Usa, Llc.

Company
Fresenius Kabi Usa, Llc
Recall Initiated
November 6, 2025
Posted
December 3, 2025
Recall Number
D-0182-2026
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
2,199,850 vials
Firm Location
Lake Zurich, IL, United States
Official Source
View on FDA website ↗

Reason for Recall

Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.

Distribution

Nationwide within the United States as well as AK, HI, and PR.

Lot / Code Info

Lot #: 6133156, 6133194, Exp Date: 08/2026; 6133388, Exp Date: 10/2026.

More recalls by Fresenius Kabi Usa, Llc

View all recalls by this company →

Other recent Class I Drug recalls